Home › Funds › Patient Square Capital LP › KYMR

Patient Square Capital LP position in KYMR

KYMERA THERAPEUTICS INC · Health Care

Patient Square Capital LP reported holding 84,000 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 1.50% of its reported portfolio and ranking #19 among its reported holdings. Patient Square Capital LP has disclosed KYMR holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)84.00K sh
Reported value held$9.39M
Portfolio Weight1.50%
First reportedQ1 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's KYMR position evolved

Patient Square Capital LP first disclosed a stake in KYMR in Q1 2025 at 142,201 shares (US$3.9M). The position peaked in Q4 2025 at 139,000 shares, worth US$10.8M. Across 7 filings, Patient Square Capital LP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 84,000 shares valued at US$9.4M — an increase of 36,500 shares quarter over quarter.. Notable position changes include a 50% increase in Q4 2025 (shares rose 7% over the following quarter), a 52% trim in Q2 2026 (shares fell 3% over the following quarter), a 77% increase in Q3 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 142.20K $3.89M New
Q2 2025 140.00K $6.11M Reduce
Q3 2025 92.59K $5.24M Reduce
Q4 2025 139.00K $10.82M Add
Q1 2026 100.00K $8.33M Reduce
Q2 2026 47.50K $5.45M Reduce
Q3 2026 84.00K $9.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has Patient Square Capital LP held KYMR?

Patient Square Capital LP has disclosed KYMR holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Patient Square Capital LP's current position in KYMR?

As of Q3 2026, Patient Square Capital LP holds 84.00K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $9.39M, representing 1.50% of its reported portfolio and ranking #19.

Has Patient Square Capital LP been buying or selling KYMR?

In the latest 13F filing (Q3 2026), Patient Square Capital LP increased its position in KYMR. The position peaked in Q4 2025 at 139.00K shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.